120 related articles for article (PubMed ID: 27858266)
1. Reverse phase protein arrays enable glioblastoma molecular subtyping.
Hutter G; Sailer M; Azad TD; von Bueren AO; Nollau P; Frank S; Tostado C; Sarvepalli D; Ghosh A; Ritz MF; Boulay JL; Mariani L
J Neurooncol; 2017 Feb; 131(3):437-448. PubMed ID: 27858266
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
4. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
5. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
6. AKT/GSK3β Signaling in Glioblastoma.
Majewska E; Szeliga M
Neurochem Res; 2017 Mar; 42(3):918-924. PubMed ID: 27568206
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.
Feng H; Li Y; Yin Y; Zhang W; Hou Y; Zhang L; Li Z; Xie B; Gao WQ; Sarkaria JN; Raizer JJ; James CD; Parsa AT; Hu B; Cheng SY
Neuro Oncol; 2015 Jun; 17(6):832-42. PubMed ID: 25468898
[TBL] [Abstract][Full Text] [Related]
8. Reverse phase protein arrays in signaling pathways: a data integration perspective.
Creighton CJ; Huang S
Drug Des Devel Ther; 2015; 9():3519-27. PubMed ID: 26185419
[TBL] [Abstract][Full Text] [Related]
9. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.
Jiang R; Mircean C; Shmulevich I; Cogdell D; Jia Y; Tabus I; Aldape K; Sawaya R; Bruner JM; Fuller GN; Zhang W
Proteomics; 2006 May; 6(10):2964-71. PubMed ID: 16619307
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.
Jovčevska I; Zupanec N; Urlep Ž; Vranič A; Matos B; Stokin CL; Muyldermans S; Myers MP; Buzdin AA; Petrov I; Komel R
Oncotarget; 2017 Jul; 8(27):44141-44158. PubMed ID: 28498803
[TBL] [Abstract][Full Text] [Related]
11. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of breast cancer using reverse phase protein arrays.
Sonntag J; Schlüter K; Bernhardt S; Korf U
Expert Rev Proteomics; 2014 Dec; 11(6):757-70. PubMed ID: 25400094
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Notch signaling activation to human glioblastoma multiforme.
Kanamori M; Kawaguchi T; Nigro JM; Feuerstein BG; Berger MS; Miele L; Pieper RO
J Neurosurg; 2007 Mar; 106(3):417-27. PubMed ID: 17367064
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients.
Xing ZY; Sun LG; Guo WJ
Clin Neurol Neurosurg; 2015 Apr; 131():54-8. PubMed ID: 25704190
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins.
Ross JL; Cooper LAD; Kong J; Gutman D; Williams M; Tucker-Burden C; McCrary MR; Bouras A; Kaluzova M; Dunn WD; Duong D; Hadjipanayis CG; Brat DJ
Sci Rep; 2017 Nov; 7(1):15593. PubMed ID: 29142297
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors.
Johnson H; White FM
Methods Mol Biol; 2018; 1711():149-164. PubMed ID: 29344889
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β pathway activity in glioblastoma.
Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
[TBL] [Abstract][Full Text] [Related]
18. Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors.
Barbus S; Tews B; Karra D; Hahn M; Radlwimmer B; Delhomme N; Hartmann C; Felsberg J; Krex D; Schackert G; Martinez R; Reifenberger G; Lichter P
J Natl Cancer Inst; 2011 Apr; 103(7):598-606. PubMed ID: 21346226
[TBL] [Abstract][Full Text] [Related]
19. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
20. Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Kim TR; Jeong HH; Sohn KA
BMC Med Genomics; 2019 Jul; 12(Suppl 5):94. PubMed ID: 31296204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
